66% Of Vetr Top Raters Bullish On GW Pharma

Shares of GW Pharmaceuticals PLC- ADR GWPH had a rough start to 2016, losing more than 44 percent through March 11. However, the stock spiked on March 14, surging more than 120 percent; the shares have traded above $70 since, having returned 12.3 percent year-to-date.

Following the strong performance seen over the past five trading days - the shares gained 8.15 percent, top raters at the Vetr community decided to upgrade the stock’s rating on Thursday, from 3.0 Stars to 3.5 Stars - out of a possible 5.0 Star rating.

Related link: Here's How Crowdsourced Ratings Can Beat The Market

With 66 percent of the crowd's ratings being bullish, users have set a price target of $83.43 per share, which implies an upside of almost 6 percent.

Disclosure: Javier Hasse holds no positions in any of the securities mentioned above.